Tesaro Cancer Drug's Results May Challenge Need for Myriad Test

·

·

Tesaro Cancer Drug's Results May Challenge Need for Myriad Test

Trial results from Tesaro Inc.'s experimental drug for ovarian cancer may challenge the need for a companion test made by Myriad Genetics Inc.,
See Original Article

Euro Bond Slide Seen Subsiding by Strategists Eyeing ECB Action

Holders of the securities have lost 0.8 percent this week but have still made 5.7 percent this year, according to data compiled by Bloomberg.
See Original Article

Attack on Refugee Camp in Niger Leaves 22 Soldiers Dead

An attack against a refugee camp in Niger on Thursday has left 22 soldiers dead. Another five military personnel were wounded in the raid on the
See Original Article

Canada Stocks Fall as Gold Stumbles, Rate Hike Expectations Rise

By John Hyland, Bloomberg News. Canadian stocks declined for a second day as employment data from the U.S. signaled that interest rates may be
See Original Article

Kuroda Says Can Lower Short, Long-Term Bond Rates If Necessary

… Japanese government bond even lower than zero percent,” Kuroda said on Saturday, speaking with Bloomberg Television's Francine Lacqua.
See Original Article



Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.